Replies to post #818280 on NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

The mhra is swell with nwbo to continue its use of dcvax within its specials program but is unwilling to approve it.
Makes perfect sense to me.

Specials has no evaluations of the drugs at all. Not even safety. P1/2 trials not required. Not even pre-clinical work. All that is required is GMP and marketing restrictions.

But never let reality get in the way of your argument.